Grand Pharmaceutical Group Limited (0512.HK)
HKD 5.93
(-0.5%)
HKD 5.93
(-0.5%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.38 Billion HKD | 3.59% |
| 2022 | 1.34 Billion HKD | 19.99% |
| 2021 | 1.11 Billion HKD | 16.94% |
| 2020 | 955.31 Million HKD | 17.31% |
| 2019 | 814.37 Million HKD | 5.72% |
| 2018 | 770.32 Million HKD | 0.97% |
| 2017 | 762.93 Million HKD | 19.92% |
| 2016 | 636.22 Million HKD | 2.34% |
| 2015 | 621.7 Million HKD | 20.35% |
| 2014 | 516.56 Million HKD | -8.13% |
| 2013 | 562.28 Million HKD | 27.13% |
| 2012 | 442.29 Million HKD | 38.58% |
| 2011 | 319.16 Million HKD | 47.65% |
| 2010 | 216.16 Million HKD | 293.26% |
| 2009 | 54.96 Million HKD | -14.51% |
| 2008 | 64.29 Million HKD | 695.93% |
| 2007 | 8.07 Million HKD | 98.14% |
| 2006 | 4.07 Million HKD | -8.32% |
| 2005 | 4.44 Million HKD | 24.11% |
| 2004 | 3.58 Million HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.29 Billion HKD | 0.0% |
| 2023 Q4 | 1.38 Billion HKD | 0.0% |
| 2023 Q2 | 1.1 Billion HKD | 0.0% |
| 2023 FY | 1.38 Billion HKD | 3.59% |
| 2022 Q4 | 1.34 Billion HKD | 0.0% |
| 2022 Q2 | 1.1 Billion HKD | 0.0% |
| 2022 FY | 1.34 Billion HKD | 19.99% |
| 2021 Q2 | 829.45 Million HKD | 0.0% |
| 2021 FY | 1.11 Billion HKD | 16.94% |
| 2021 Q4 | 1.11 Billion HKD | 0.0% |
| 2020 Q4 | 955.31 Million HKD | 0.0% |
| 2020 Q2 | 810.79 Million HKD | 0.0% |
| 2020 FY | 955.31 Million HKD | 17.31% |
| 2019 FY | 814.37 Million HKD | 5.72% |
| 2019 Q4 | 814.37 Million HKD | 0.0% |
| 2019 Q2 | 752.42 Million HKD | 0.0% |
| 2018 Q2 | 735.64 Million HKD | 0.0% |
| 2018 Q4 | 770.32 Million HKD | 0.0% |
| 2018 FY | 770.32 Million HKD | 0.97% |
| 2017 Q4 | 762.93 Million HKD | 0.0% |
| 2017 FY | 762.93 Million HKD | 19.92% |
| 2017 Q2 | 677.81 Million HKD | 0.0% |
| 2016 Q4 | 636.22 Million HKD | 0.0% |
| 2016 Q2 | 539.06 Million HKD | 0.0% |
| 2016 FY | 636.22 Million HKD | 2.34% |
| 2015 Q4 | 621.7 Million HKD | 0.0% |
| 2015 FY | 621.7 Million HKD | 20.35% |
| 2015 Q2 | 510.76 Million HKD | 0.0% |
| 2014 Q4 | 516.56 Million HKD | 0.0% |
| 2014 FY | 516.56 Million HKD | -8.13% |
| 2014 Q2 | 441.16 Million HKD | 0.0% |
| 2013 Q4 | 562.28 Million HKD | 0.0% |
| 2013 Q2 | 432.82 Million HKD | 0.0% |
| 2013 FY | 562.28 Million HKD | 27.13% |
| 2012 FY | 442.29 Million HKD | 38.58% |
| 2012 Q2 | 315.87 Million HKD | 0.0% |
| 2012 Q4 | 442.29 Million HKD | 0.0% |
| 2011 Q4 | 319.16 Million HKD | 0.0% |
| 2011 Q2 | 255.21 Million HKD | 0.0% |
| 2011 FY | 319.16 Million HKD | 47.65% |
| 2010 Q2 | 136.5 Million HKD | 0.0% |
| 2010 FY | 216.16 Million HKD | 293.26% |
| 2010 Q4 | 216.16 Million HKD | 0.0% |
| 2009 Q4 | 54.96 Million HKD | 0.0% |
| 2009 FY | 54.96 Million HKD | -14.51% |
| 2009 Q2 | 52.38 Million HKD | 0.0% |
| 2008 Q4 | 64.29 Million HKD | 0.0% |
| 2008 FY | 64.29 Million HKD | 695.93% |
| 2007 FY | 8.07 Million HKD | 98.14% |
| 2006 FY | 4.07 Million HKD | -8.32% |
| 2005 FY | 4.44 Million HKD | 24.11% |
| 2004 FY | 3.58 Million HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -11285.169% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -19014.233% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | -350.717% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | -221.606% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | -365.824% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -2110.453% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -1313.153% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -690.816% |
| SSY Group Limited | 1.08 Billion HKD | -27.835% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -1416.241% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | -336.879% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 96.043% |